Cardiovascular dynamics after acute and long-term alpha- and beta-adrenoceptor blockade at rest, supine and standing, and during exercise
- PMID: 43162
- PMCID: PMC1429733
Cardiovascular dynamics after acute and long-term alpha- and beta-adrenoceptor blockade at rest, supine and standing, and during exercise
Abstract
1 After acute intravenous administration labetalol reduced mean values for BP, total peripheral resistance, heart rate and cardiac output. All changes were more pronounced during bicycle exercise. 2 After a mean duration of 20 months' treatment with oral labetalol the haemodynamic findings were broadly similar except for a more marked reduction in the total peripheral resistance and cardiac output had returned to pretreatment level due to an increased stroke volume which had counter balanced the reduction in heart rate. These changes occurred at rest, in the erect position and during exercise but the reductions in BP and peripheral resistance were most marked during exercise. 3 Left ventricular filling pressures and stroke volume/filling pressure ratios were not significantly altered after intravenous labetalol compared with pretreatment values. 4 Systolic BP x heart rate product was lowered particularly during exercise after both intravenous and oral labetalol. 5 After long-term oral labetalol, the most striking haemodynamic change was in the elevated resting stroke volume supine and standing.
Similar articles
-
Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):725-8. Br J Clin Pharmacol. 1976. PMID: 10950
-
Cardiovascular dynamics after acute and long-term alpha- and beta- adrenoceptor blockade at rest, supine and standing, and during exercise.Br J Clin Pharmacol. 1979 Apr;8 Suppl 2:101S-5S. doi: 10.1111/j.1365-2125.1979.tb04762.x. Br J Clin Pharmacol. 1979. PMID: 26635148
-
Sequential haemodynamic effects of labetalol at rest and during exercise in essential hypertension.Postgrad Med J. 1980;56 Suppl 2:21-6. Postgrad Med J. 1980. PMID: 7433338
-
Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.Drugs. 1984;28 Suppl 2:35-50. doi: 10.2165/00003495-198400282-00004. Drugs. 1984. PMID: 6151890 Review.
-
Hemodynamic changes after acute and long-term combined alpha--beta-adrenoceptor blockade with labetalol as compared with beta-receptor blockade.J Cardiovasc Pharmacol. 1981;3 Suppl 1:S30-41. doi: 10.1097/00005344-198100031-00004. J Cardiovasc Pharmacol. 1981. PMID: 6169958 Review.
Cited by
-
Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.Klin Wochenschr. 1983 Jul 1;61(13):661-7. doi: 10.1007/BF01487583. Klin Wochenschr. 1983. PMID: 6310204
-
Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.Br J Clin Pharmacol. 1979;8(Suppl 2):239S-244S. Br J Clin Pharmacol. 1979. PMID: 526408 Free PMC article. No abstract available.
-
Comparison of labetalol with other anti-hypertensive drugs.Br J Clin Pharmacol. 1982 Jun;13(1 Suppl):41S-47S. doi: 10.1111/j.1365-2125.1982.tb01888.x. Br J Clin Pharmacol. 1982. PMID: 6124265 Free PMC article. Review.
-
Antihypertensive and metabolic effects of nifedipine and labetalol alone and in combination in primary hypertension.Eur J Clin Pharmacol. 1985;29(2):149-54. doi: 10.1007/BF00547413. Eur J Clin Pharmacol. 1985. PMID: 3908121 Clinical Trial.
-
Properties of labetalol, a combined alpha- and beta-blocking agent, relevant to the treatment of myocardial ischemia.Cardiovasc Drugs Ther. 1988 Sep;2(3):343-53. doi: 10.1007/BF00054642. Cardiovasc Drugs Ther. 1988. PMID: 2908732 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources